{"nct_id":"NCT02728895","title":"Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2016-06-15","start_date_type":"ACTUAL","primary_completion_date":"2018-07-10","primary_completion_date_type":"ACTUAL","completion_date":"2018-07-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TAK"]}